NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

26.67

-1.16 (-4.17%)

At close: Aug 13, 2026, 4:00 PM EDT

27.20

+0.53 (1.99%)

After-hours: Aug 13, 2026, 7:34 PM EDT

NAMS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	424.15	490	771.74	340.45	467.73	60.37
Short-Term Investments	209.7	146.24	62.45	-	-	-
Cash & Short-Term Investments	633.85	636.24	834.19	340.45	467.73	60.37
Cash Growth	-14.25%	-23.73%	145.03%	-27.21%	674.73%	-
Other Current Assets	25.35	39.46	29.22	6.34	10.25	6.57
Total Current Assets	659.21	675.7	863.41	346.79	477.98	66.95
Net Property, Plant & Equipment	0.49	0.57	0.67	0.1	0.15	0.22
Other Intangible Assets	0.34	93.2	88.7	88.7	88.7	-
Long-Term Investments	44.41	92.61	-	-	-	-
Other Long-Term Assets	-	-	-	0.04	0.16	0.82
Total Assets	704.45	862.08	952.78	435.62	566.99	67.98
Accounts Payable	5.42	8.97	4.74	16.92	11.85	11.17
Accrued Expenses	10.28	29.06	20.9	14.88	7.88	-
Current Portion of Leases	0.03	0.14	0.25	0.06	0.07	0.06
Unearned Revenue	2.8	3.99	6.01	8.94	13.87	-
Other Current Liabilities	54.45	57.27	37.51	12.57	4.15	-
Total Current Liabilities	72.97	99.42	69.41	53.38	37.82	11.23
Long-Term Leases	0.06	0.07	0.2	-	0.06	0.13
Other Long-Term Liabilities	-	-	44.8	8.81	12.31	-
Total Long-Term Liabilities	0.06	0.07	45	8.81	12.37	0.13
Total Liabilities	73.03	99.49	114.41	62.18	50.2	11.36
Common Stock	14.74	14.28	13.44	10.17	10.06	95.38
Additional Paid-in Capital	1,488	1,507	1,378	670.78	635.64	0.67
Accumulated Other Comprehensive Income	3.86	0.84	0.51	0.47	0.47	-
Retained Earnings	-874.97	-759.29	-553.76	-307.98	-129.37	-39.43
Shareholders' Equity	631.42	762.59	838.37	373.44	516.79	56.62
Total Liabilities & Equity	704.45	862.08	952.78	435.62	566.99	67.98
Total Debt	0.08	0.2	0.45	0.06	0.13	0.19
Net Cash (Debt)	633.77	636.04	833.74	340.39	467.6	60.19
Net Cash Growth	-14.22%	-23.71%	144.94%	-27.21%	676.92%	-
Net Cash Per Share	5.24	5.37	8.84	4.14	24.65	2.55
Book Value	631.42	762.59	838.37	373.44	516.79	56.62
Book Value Per Share	5.22	6.44	8.88	4.55	27.25	2.40
Tangible Book Value	631.08	669.39	749.67	284.74	428.09	56.62
Tangible Book Value Per Share	5.21	5.65	7.94	3.47	22.57	2.40

SEC Filings: 10-K · 10-Q